Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Morgan Stanley analyst Carlos De Alba downgraded Alcoa Corp (NYSE:AA) from Overweight to Equal-Weight and lowered the price target from $79 to $53. Alcoa shares closed at $49.01 on Tuesday. See how other analysts view this stock.
  • Baird analyst Eric Coldwell downgraded Medpace Holdings Inc (NASDAQ:MEDP) from Outperform to Neutral and raised the price target from $477 to $547. Medpace shares closed at $546.29 on Tuesday. See how other analysts view this stock.
  • B of A Securities analyst Ebrahim Poonawala downgraded Truist Financial Corp (NYSE:TFC) from Buy to Neutral and raised the price target from $54 to $56. Truist Financial shares closed at $51.36 on Tuesday. See how other analysts view this stock.
  • Barclays analyst Andrew Mok downgraded HCA Healthcare Inc (NYSE:HCA) from Overweight to Equal-Weight and slashed the price target from $496 to $427. HCA Healthcare shares closed at $423.11 on Tuesday. See how other analysts view this stock.
  • Keefe, Bruyette & Woods analyst Meyer Shields downgraded Travelers Companies Inc (NYSE:TRV) from Outperform to Market Perform and raised the price target from $342 to $356. Travelers shares closed at $343.73 on Tuesday. See how other analysts view this stock.

Considering buying HCA stock? Here’s what analysts think:

Photo via Shutterstock